GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heartseed Inc (TSE:219A) » Definitions » Issuance of Debt

Heartseed (TSE:219A) Issuance of Debt : 円0.0 Mil (TTM As of Oct. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Heartseed Issuance of Debt?

Heartseed's Issuance of Debt for the six months ended in Oct. 2024 was 円0.0 Mil.

Heartseed's Issuance of Debt for the trailing twelve months (TTM) ended in Oct. 2024 was 円0.0 Mil.


Heartseed Issuance of Debt Historical Data

The historical data trend for Heartseed's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartseed Issuance of Debt Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24
Issuance of Debt
- - -

Heartseed Semi-Annual Data
Oct22 Oct23 Apr24 Oct24
Issuance of Debt - - - -

Heartseed Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Oct. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heartseed Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Heartseed's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartseed Business Description

Traded in Other Exchanges
N/A
Address
1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is engaged in developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.

Heartseed Headlines

No Headlines